Tapentadol and Zolpidem drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tapentadol (tapentadol) and Zolpidem (zolpidem tartrate). Common drug interactions include stomatitis among females and alcohol interaction among males.

The phase IV clinical study analyzes what interactions people have when they take Tapentadol and Zolpidem. It is created by eHealthMe based on reports of 82 people who take the same drugs from the FDA, and is updated regularly.

What is Tapentadol?

Tapentadol has active ingredients of tapentadol. It is often used in chronic pain. eHealthMe is studying from 2,551 Tapentadol users. Check the latest studies of Tapentadol.

What is Zolpidem?

Zolpidem has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 92,695 Zolpidem users. Check the latest studies of Zolpidem.



On Jul, 13, 2026

82 people who take Tapentadol and Zolpidem together, and have interactions are studied.

Tapentadol and Zolpidem drug interactions.

What are the common drug interactions of Tapentadol and Zolpidem, by gender? *:

female:

  1. Stomatitis (inflammation of mucous membrane of mouth)
  2. Tendonitis (a condition that causes pain and swelling of tendons)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Tinnitus (a ringing in the ears)
  5. Vision blurred
  6. Vitamin d decreased
  7. Wound
  8. Activities of daily living impaired
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Bedridden

male:

  1. Alcohol interaction
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  4. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  5. Renal failure (kidney dysfunction)
  6. Renal hypertension (high blood pressure caused by the kidneys hormonal response)
  7. Fatigue (feeling of tiredness)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Abdominal pain
  10. Arthralgia (joint pain)

What are the common drug interactions of Tapentadol and Zolpidem, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Depression
  2. Drug ineffective
  3. Dysuria (painful or difficult urination)
  4. Fatigue (feeling of tiredness)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Suicidal ideation
  7. Weight increased
  8. Abnormal behaviour
  9. Anxiety
  10. Pain

20-29:

  1. Intentional self-injury
  2. Mydriasis (a dilation of the pupil)

30-39:

  1. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

40-49:

  1. Transferrin saturation increased
  2. Completed suicide (act of taking one's own life)
  3. Serum ferritin increased
  4. Social problem

50-59:

  1. Colitis (inflammation of colon)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Syncope (loss of consciousness with an inability to maintain postural tone)
  4. Adverse drug reaction
  5. Chronic kidney disease
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Impaired gastric emptying
  8. Renal failure (kidney dysfunction)
  9. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  10. Urine osmolarity decreased

60+:

  1. Alcohol interaction
  2. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Pain
  5. Skin lesion
  6. Weight decreased
  7. Asthenia (weakness)
  8. Confusional state
  9. Fatigue (feeling of tiredness)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Cancer Pain: 12 people, 14.63%
  2. Pain: 8 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Tapentadol and Zolpidem?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tapentadol and Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tapentadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zolpidem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tapentadol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zolpidem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tapentadol and zolpidem tartrate (the active ingredients of Tapentadol and Zolpidem, respectively), and Tapentadol and Zolpidem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: